1) transport disc
骨转移盘
1.
A complete perforative cleft was established in every dog, however, transport disc was produced w.
2只为对照组,只在硬腭后部形成8mm×30mm全层洞穿缺损裂隙,5只在形成缺损的同时安置DO装置,并形成骨转移盘,术后12天开始以每次0。
2) Bone metastasis
骨转移
1.
Clinical evaluation of ibandronate in treatment of tumorous bone metastasis;
伊班膦酸钠治疗恶性肿瘤骨转移临床评价
2.
Curative effect of bone metastasis cancer pain by bonin and bonin combined chemotherapy;
帕米膦酸二钠和帕米膦酸二钠联合化疗治疗恶性肿瘤骨转移疼痛的疗效观察
3.
Clinical significance of PSA and ECT in diagnosis of prostate cancer with bone metastasis;
PSA、ECT骨显像诊断前列腺癌骨转移的临床意义
3) bone metastases
骨转移
1.
Radiotherapeutic management and prognostic factors for patients with bone metastases of postoperative breast cancer;
乳腺癌术后骨转移的放射治疗和预后因素
2.
The clinical value of serum Tracp5b as a marker to diagnose bone metastases in breast cancer patients;
血清Tracp5b诊断乳腺癌骨转移的临床价值
3.
Effects of Ibandronate in combination with chemotherapy in patients with cancer and bone metastases;
伊班膦酸钠治疗22例晚期恶性肿瘤骨转移疗效分析
4) bone metastases
骨转移瘤
1.
Clinical observation of the treatment for bone metastases with ~(153)Sm-EDTMP;
~(153)钐-乙二胺四亚甲基膦酸治疗骨转移瘤的疗效观察
2.
Immunological functions between effective and ineffective patients with bone metastases after therapy of ~(153)Sm-EDTMP;
核素治疗骨转移瘤有效和无效患者的免疫功能分析
3.
CD_4~+,CD_8~+ and CD_4~+/CD_8~+ in estimating therapeutic effects of bone metastases;
CD_4~+,CD_8~+及CD_4~+/CD_8~+对于骨转移瘤治疗效果的监控作用(英文)
5) Skeletal metastasis
骨转移
1.
The Diagnostic Role of PSA、FPSA and Bone Scintigraphy for Skeletal Metastasis of Prostate Cancer;
PSA、FPSA检测和骨显像对前列腺癌骨转移的诊断价值
2.
The skeletal metastasis in nasopharyngeal carcinoma(NPC): clinical analysis of 136 cases;
鼻咽癌骨转移(附136例临床分析)
3.
Objective To evaluate the value of prostate specific antigen(PSA),complexed prostate specific antigen(cPSA) and bone scintigraphic imaging in diagnosis of early skeletal metastasis of prostate cancer.
目的:分析前列腺特异性抗原(PSA)、复合前列腺特异性抗原(cPSA)联检和核素全身骨显像对前列腺癌早期骨转移的诊断价值。
6) metastatic bone tumour
骨转移癌
1.
Objective:To evaluate the efficacy of zoledronic acid combined with radiotherapy for metastatic bone tumours.
目的:观察唑来膦酸联合放疗治疗骨转移癌的疗效。
2.
Methods:Total of 100 patients with metastatic bone tumours were randomly divided into there groups:35 cases in the group A were only treated by radiotherapy;Pamidronate was applied in the group B including 30 cases;and the other 35 cases were treated by radiotherapy combined with pamidronate in the group C.
目的:观察局部放疗联合帕米磷酸二钠治疗骨转移癌疼痛的疗效及不良反应。
参考词条
补充资料：正常人白细胞转移因子 , 白细胞转移因子,转移因子
药物名称：转移因子
英文名：Transfer Factor
别名： 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名：Transfer Factor ,TF
适应症： 为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。
用量用法：
一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。
规格： 注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000.
注：严禁静脉给药.
类别：免疫调节剂
英文名：Transfer Factor
别名： 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名：Transfer Factor ,TF
适应症： 为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。
用量用法：
一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。
规格： 注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000.
注：严禁静脉给药.
类别：免疫调节剂
说明：补充资料仅用于学习参考，请勿用于其它任何用途。